Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Patents: Applications Pending, 2003

Deciphera Pharmaceuticals, Inc. Patent Applications Pending

3 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2003-12-26: Application PCTUS2003041450; Invention MODULATION OF PROTEIN FUNCTIONALITIES; Applicant DECIPHERA PHARMACEUTICALS, LLC; Status PCT - IPER (International Preliminary Examination Report) 409-416 Mailed.
  • 2003-12-26: Application PCTUS2003041449; Invention ANTI-INFLAMMATORY MEDICAMENTS; Applicant DECIPHERA PHARMACEUTICALS, LLC; Status PCT - IPER (International Preliminary Examination Report) 409-416 Mailed.
  • 2003-12-26: Application PCTUS2003041425; Invention ANTI-CANCER MEDICAMENTS; Applicant DECIPHERA PHARMACEUTICALS, INC.; Status PCT - IPER (International Preliminary Examination Report) 409-416 Mailed.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2003-12-26PCTUS2003041450MODULATION OF PROTEIN FUNCTIONALITIESDECIPHERA PHARMACEUTICALS, LLCPCT - IPER (International Preliminary Examination Report) 409-416 Mailed
PETER A. PETRILLO
DANIEL L. FLYNN
United States
United States
DAVIS, DEBORAH A
2003-12-26PCTUS2003041449ANTI-INFLAMMATORY MEDICAMENTSDECIPHERA PHARMACEUTICALS, LLCPCT - IPER (International Preliminary Examination Report) 409-416 Mailed
PETER A. PETRILLO
DANIEL L. FLYNN
United States
United States
PAVIGLIANITI, ANTHONY JOSEPH
2003-12-26PCTUS2003041425ANTI-CANCER MEDICAMENTSDECIPHERA PHARMACEUTICALS, INC.PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
PETER A. PETRILLO
DANIEL L. FLYNN
United States
United States
RAO, DEEPAK R